companies innovating in obesity treatment glp-1 drugs 2025 What's next for innovation: A primer on the race reshaping pharma and chronic disease care How to Invest in GLP-1

A study on female endurance athletes found that carb restriction after high-intensity training did not impair next-day performance (though notethis wasnt a fasted workout)

Circadian control of the NAD + salvage pathway by CLOCK-SIRT1

were the O-pill (norgestrel) oral contraceptive and Narcan (naloxone) opioid overdose nasal spray, which both were approved for OTC in 2023

Stomach & Waistline Flatten and contour your midsection

Published clinical evidence includes a Phase 1b multiple-ascending-dose trial reported by Enebo and colleagues (Lancet, 2021) and a Phase 2 trial in type 2 diabetes reported by Frias and colleagues (Lancet, 2023), both studying cagrilintide together with semaglutide

Coated with crunchy dark chocolate, these bars are available in two flavours: Chocolate Tangerine and Raspberry Brownie